Further analysis of subgroups found that the upregulation of PIMREG was associated with worse OS in infiltrating lobular carcinoma with HR of 2.79 (95%CI [1.13–6.75]; P = 0.026), but not in infiltrating ductal carcinoma. Here, PIMREG is linked to invasive ductal breast carcinoma.